Skip to main navigation Skip to search Skip to main content

Substandard and Falsified Medications: A Barrier to Global Health Equity Exemplified in Ecuador

  • Aleksandra Yakhkind
  • , Adam Edward Lang*
  • , Gretchen Brophy
  • , Eljim Tesoro
  • , Kimberly E. Levasseur-Franklin
  • , Nelson Maldonado
  • *Corresponding author for this work
  • Tufts University School of Medicine
  • McDonald Army Health Center
  • Virginia Commonwealth University
  • Virginia Commonwealth University
  • University of Illinois at Chicago
  • Tufts Medical Center

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Medicines have been developed and have become globalized at a pace faster than traditional medical education can keep up. Physicians, pharmacists, nurses, and advanced practice providers learn the names and functions of these medications, but not how they are made and how they get to the bedside. The often economically driven intricacies behind these processes have a dramatic effect on patient care and outcomes. A staggering proportion of medications worldwide are reported to be substandard or falsified. This article explores one country’s story of how medication gets to the bedside, describes how this process can go wrong, and outlines what providers can do to work toward the goal of equitable access to quality medications for all.

Original languageEnglish
Pages (from-to)1-6
Number of pages6
JournalNeurocritical Care
Volume38
Issue number1
DOIs
StatePublished - 14 Dec 2022

Keywords

  • Falsified medications
  • Global health
  • Substandard medications
  • Ecuador
  • Global Health
  • Physicians
  • Humans
  • Counterfeit Drugs

Fingerprint

Dive into the research topics of 'Substandard and Falsified Medications: A Barrier to Global Health Equity Exemplified in Ecuador'. Together they form a unique fingerprint.

Cite this